Trial Condition(s):

Dermatitis, Atopic

Efficacy and tolerance of once-daily methylprednisolone aceponate ointment in comparison with twice-daily hydrocortisone 17-butyrate in patients with atopic dermatitis

Bayer Identifier:

Trial_89172

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
213
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information

Not Available